News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,155 Results
Type
Article (57578)
Company Profile (666)
Press Release (693911)
Multimedia
Podcasts (108)
Webinars (14)
Section
Business (212022)
Career Advice (3395)
Deals (37450)
Drug Delivery (123)
Drug Development (85617)
Employer Resources (185)
FDA (17192)
Job Trends (16360)
News (362681)
Policy (35132)
Tag
Academia (2870)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (95)
Alliances (52044)
ALS (104)
Alzheimer's disease (1492)
Antibody-drug conjugate (ADC) (162)
Approvals (17147)
Artificial intelligence (299)
Autoimmune disease (29)
Automation (15)
Bankruptcy (388)
Best Places to Work (12365)
BIOSECURE Act (22)
Biosimilars (116)
Biotechnology (460)
Bladder cancer (84)
Brain cancer (32)
Breast cancer (312)
Cancer (2468)
Cardiovascular disease (204)
Career advice (2869)
Career pathing (34)
CAR-T (176)
Cell therapy (493)
Cervical cancer (21)
Clinical research (69352)
Collaboration (931)
Company closure (2)
Compensation (570)
Complete response letters (30)
COVID-19 (2816)
CRISPR (50)
C-suite (275)
Cystic fibrosis (108)
Data (2352)
Decentralized trials (2)
Denatured (34)
Depression (55)
Diabetes (296)
Diagnostics (6823)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (134)
Drug pricing (126)
Drug shortages (32)
Duchenne muscular dystrophy (104)
Earnings (86387)
Editorial (47)
Employer branding (24)
Employer resources (158)
Events (123292)
Executive appointments (782)
FDA (18591)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (821)
Gene editing (125)
Generative AI (27)
Gene therapy (363)
GLP-1 (844)
Government (4810)
Grass and pollen (6)
Guidances (148)
Healthcare (20235)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (150)
Indications (30)
Infectious disease (2973)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (101)
Interviews (664)
IPO (17472)
IRA (50)
Job creations (4486)
Job search strategy (2346)
Kidney cancer (10)
Labor market (44)
Layoffs (557)
Leadership (24)
Legal (8464)
Liver cancer (82)
Lung cancer (348)
Lymphoma (160)
Machine learning (9)
Management (62)
Manufacturing (361)
MASH (81)
Medical device (14381)
Medtech (14386)
Mergers & acquisitions (20557)
Metabolic disorders (791)
Multiple sclerosis (89)
NASH (23)
Neurodegenerative disease (116)
Neuropsychiatric disorders (34)
Neuroscience (2101)
NextGen: Class of 2025 (7312)
Non-profit (4681)
Now hiring (41)
Obesity (426)
Opinion (272)
Ovarian cancer (83)
Pain (104)
Pancreatic cancer (90)
Parkinson's disease (161)
Partnered (22)
Patents (253)
Patient recruitment (118)
Peanut (51)
People (61470)
Pharmaceutical (133)
Pharmacy benefit managers (22)
Phase I (21656)
Phase II (30489)
Phase III (22905)
Pipeline (1393)
Policy (177)
Postmarket research (2696)
Preclinical (9292)
Press Release (70)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (434)
Real estate (6565)
Recruiting (73)
Regulatory (24185)
Reports (42)
Research institute (2568)
Resumes & cover letters (538)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (81)
Series A (144)
Series B (94)
Service/supplier (26)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (160)
Sponsored (34)
Startups (4060)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (54)
The Weekly (73)
Vaccines (808)
Venture capitalists (45)
Weight loss (296)
Women's health (38)
Worklife (20)
Date
Last 7 days (978)
Last 30 days (3109)
Last 365 days (34607)
2025 (12435)
2024 (37643)
2023 (42286)
2022 (53555)
2021 (58189)
2020 (56725)
2019 (49750)
2018 (37861)
2017 (35630)
2016 (35727)
2015 (41418)
2014 (34550)
2013 (29490)
2012 (31191)
2011 (31450)
2010 (29186)
Location
Africa (1008)
Alabama (60)
Alaska (7)
Arizona (214)
Arkansas (14)
Asia (44767)
Australia (7554)
California (6654)
Canada (2102)
China (573)
Colorado (286)
Connecticut (303)
Delaware (165)
Europe (100370)
Florida (974)
Georgia (224)
Hawaii (1)
Idaho (60)
Illinois (616)
India (29)
Indiana (340)
Iowa (12)
Japan (175)
Kansas (108)
Kentucky (26)
Louisiana (14)
Maine (70)
Maryland (944)
Massachusetts (5096)
Michigan (247)
Minnesota (426)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (25)
Nevada (68)
New Hampshire (68)
New Jersey (1873)
New Mexico (31)
New York (1876)
North Carolina (1133)
North Dakota (8)
Northern California (2870)
Ohio (220)
Oklahoma (15)
Oregon (46)
Pennsylvania (1459)
Puerto Rico (14)
Rhode Island (36)
South America (1379)
South Carolina (24)
South Dakota (1)
Southern California (2473)
Tennessee (103)
Texas (991)
United States (25242)
Utah (197)
Virginia (172)
Washington D.C. (71)
Washington State (610)
West Virginia (3)
Wisconsin (68)
752,155 Results for "the medicines company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biomea Fusion to Become a Diabetes & Obesity Medicines Company
January 14, 2025
·
8 min read
Press Releases
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
April 18, 2025
·
4 min read
Cell therapy
Galapagos to Spin Out Innovative Medicines, Lay Off 40%
By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell therapy company, the latter of which will inherit the Galapagos name.
January 8, 2025
·
3 min read
·
Tristan Manalac
Obesity
WHO Leaning Toward Adding Obesity Drugs for Adults to Essential Medicines List:
Reuters
In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, which the agency decided against listing in 2023, the last time the Essential Medicines list was updated.
May 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines
March 3, 2025
·
14 min read
Press Releases
Scipher Medicine and InnoSIGN Announce Partnership to Advance Precision Medicine in Immunology
April 30, 2025
·
3 min read
Press Releases
HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases
May 8, 2025
·
5 min read
Press Releases
BlossomHill Therapeutics to Present the Design and Discovery of BH-30643, the Company’s OMNI-EGFR™ Inhibitor, at the 2025 AACR Annual Meeting
April 3, 2025
·
3 min read
Press Releases
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates
May 2, 2025
·
1 min read
Press Releases
Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress
May 8, 2025
·
12 min read
1 of 75,216
Next
